Biotech drugs - revenues
This statistic shows the revenues of selected key biotech drugs in 2010. In that year, the revenue of biotech drug Rituxan was at 6.6 billion U.S. dollars.
You only have access to basic statistics.
This statistic is not included in your account.
Business Solutions including all features.
About the industry
About the region
Selected statistics
Other regions
Related statistics
Further related statistics